MedTrace Logo

French Validation of the Dual Diagnosis Screening Interview (F_DDSI)

NCT03585842 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2018-07-13

No results posted yet for this study

Summary

In France, there are no tools for screening psychiatric comorbidities for individuals with Substance Use Disorders. The literature shows that the cooccurrence of these psychiatric disorders in the same individual is frequent. It negatively impacts the healing prognosis, complicates the diagnostic processes and the type of care to be introduced for patients. The creation of reliable, fast and easy-to-use tools for caregivers and researchers is therefore necessary to improve quantitatively and qualitatively the care of patients. There is a Spanish scale that meets these criteria, the Dual Diagnostic Screening Interview (S\_DDSI). The main objective of this study is to validate the DDSI in French. The secondary objectives are the evaluation of the psychometric qualities of F\_DDSI (French version) and adaptation of this scale into an application for Android and iOS.

Conditions

  • Substance Related Disorders
  • Psychiatric Comorbidities

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Georges BROUSSE, PhD · University Hospital, Clermont-Ferrand

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-14
Primary Completion
2019-01-31
Completion
2019-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03585842 on ClinicalTrials.gov